AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 193 filers reported holding AUDENTES THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 5.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $9,832,000 | -25.8% | 350,000 | 0.0% | 0.39% | -26.5% |
| Q2 2019 | $13,251,000 | -15.1% | 350,000 | -12.5% | 0.54% | -15.9% |
| Q1 2019 | $15,608,000 | +22.0% | 400,000 | -33.3% | 0.64% | +34.4% |
| Q4 2018 | $12,792,000 | +29.2% | 600,000 | +140.0% | 0.47% | +83.7% |
| Q3 2018 | $9,898,000 | +9.8% | 250,000 | +5.9% | 0.26% | +34.4% |
| Q2 2018 | $9,018,000 | +100.0% | 236,000 | +57.3% | 0.19% | +242.9% |
| Q1 2018 | $4,508,000 | -27.9% | 150,000 | -25.0% | 0.06% | -40.4% |
| Q4 2017 | $6,250,000 | +11.6% | 200,000 | 0.0% | 0.09% | -3.1% |
| Q3 2017 | $5,602,000 | – | 200,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
| Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
| Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
| Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
| Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
| Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
| Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
| Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
| Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |